Simplicity Solutions’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$710K Sell
22,305
-1,669
-7% -$52.4K 0.02% 549
2023
Q3
$846K Sell
23,974
-452
-2% -$17.2K 0.03% 457
2023
Q2
$928K Sell
24,426
-621
-2% -$24.8K 0.03% 479
2023
Q1
$946K Buy
25,047
+5,064
+25% +$195K 0.02% 500
2022
Q4
$847K Buy
19,983
+458
+2% +$18.9K 0.12% 228
2022
Q3
$627K Buy
19,525
+1,510
+8% +$53K 0.09% 270
2022
Q2
$585K Buy
18,015
+1,000
+6% +$32.4K 0.08% 276
2022
Q1
$616K Sell
17,015
-12,171
-42% -$418K 0.08% 268
2021
Q4
$1.15M Buy
29,186
+16,489
+130% +$688K 0.13% 201
2021
Q3
$555K Buy
12,697
+1,895
+18% +$85.1K 0.09% 259
2021
Q2
$441K Buy
10,802
+1,555
+17% +$60K 0.09% 257
2021
Q1
$304K Buy
+9,247
New +$348K 0.07% 328

Other funds holding GMAB

Simplicity Solutions's GMAB Position: Q4 2023 in Review

Simplicity Solutions reduced its Genmab (GMAB) stake by 7% in Q4 2023, selling an estimated $52.4K and leaving 22,305 shares worth $710K. The position accounts for 0.02% of the portfolio, ranked #549.

Simplicity Solutions first reported a position in GMAB in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.15M in Q4 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Simplicity Solutions held 22,305 shares of Genmab worth $710K as of Q4 2023.
  • Simplicity Solutions sold 1,669 Genmab shares in Q4 2023, an estimated $52.4K.
  • Genmab made up 0.02% of Simplicity Solutions's portfolio in Q4 2023, its #549 holding.
  • Simplicity Solutions first reported a position in Genmab in Q1 2021 and has held it in 12 quarters since.
  • Simplicity Solutions's Genmab position peaked at $1.15M in Q4 2021.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.